Daunorubicin hydrochloride (Synonyms: Daunomycin hydrochloride; RP 13057 hydrochloride; Rubidomycin hydrochloride)

Name: Daunorubicin hydrochloride
Brand: MedChemExpress
SKU: HY-13062
Rating: 5.0 (25 reviews)

Cat. No.: HY-13062 Purity: 99.67%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor.

For research use only. We do not sell to patients.

Daunorubicin hydrochloride Chemical Structure

CAS No. : 23541-50-6

Size	Price	Stock	Quantity

Free Sample (0.1 - 0.5 mg)		Apply Now
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 72	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 72	In-stock	Estimated Time of Arrival: December 31
Solid
5 mg	USD 41	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 65	In-stock	Estimated Time of Arrival: December 31
50 mg	USD 150	In-stock	Estimated Time of Arrival: December 31
100 mg	USD 250	In-stock	Estimated Time of Arrival: December 31
200 mg	USD 380	In-stock	Estimated Time of Arrival: December 31
500 mg	USD 594	In-stock	Estimated Time of Arrival: December 31
1 g		Get quote
5 g		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 25 publication(s) in Google Scholar

Other Forms of Daunorubicin hydrochloride:

Daunorubicin citrate Get quote
Daunorubicin Get quote
Daunorubicin hydrochloride (Standard) Get quote

25 Publications Citing Use of MCE Daunorubicin hydrochloride

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All Topoisomerase Isoform Specific Products:

View All Isoforms

Topoisomerase Topo I Topo II

View All ADC Cytotoxin Isoform Specific Products:

View All Isoforms

Auristatin Calicheamicins Camptothecins Daunorubicins/Doxorubicins Duocarmycins Maytansinoids Pyrrolobenzodiazepines Traditional Cytotoxic Agents

View All Antibiotic Isoform Specific Products:

View All Isoforms

Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam

Biological Activity
Purity & Documentation
References
Customer Review

Description

IC₅₀ & Target^[1]^[2]

Topoisomerase II

Daunorubicins/Doxorubicins

Cellular Effect

Cell Line	Type	Value	Description	References
CAPAN-1	IC₅₀	3.1 μM Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against Capen-1 cell line (pancreatic carcinoma) after incubation for 72 hour Cytotoxicity of compound was tested against Capen-1 cell line (pancreatic carcinoma) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
CAPAN-1	IC₅₀	3.9 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against Capan-1 cell line (pancreatic carcinoma) after incubation for 24 hour Cytotoxicity of compound was tested against Capan-1 cell line (pancreatic carcinoma) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
CHO	IC₅₀	2.94 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 72 hour Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
CHO	IC₅₀	3.9 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 24 hour Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
HCT-116	IC₅₀	0.28 μg/mL Compound: Daunorubicin HCl	Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay	[PMID: 12141872]
HeLa	IC₅₀	0.32 μM Compound: Daunorubicin	Cytotoxicity against human HeLa cells after 48 hrs by MTT assay Cytotoxicity against human HeLa cells after 48 hrs by MTT assay	[PMID: 17190447]
HL-60	IC₅₀	< 9.8 x 10^-8 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 24 hour Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
HL-60	IC₅₀	9.8 x 10^-8 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 72 hour Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
HMEC	IC₅₀	< 9.8 x 10^-8 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 72 hour Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
HMEC	IC₅₀	3.9 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 24 hour Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
HRT-18 cell line	IC₅₀	0.11 μg/mL Compound: Daunorubicin HCl	Cytotoxicity against human HRT18 cells after 48 hrs by MTT assay Cytotoxicity against human HRT18 cells after 48 hrs by MTT assay	[PMID: 12141872]
HT-29	IC₅₀	0.072 μg/mL Compound: Daunorubicin HCl	Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay	[PMID: 12141872]
HT-29	IC₅₀	3.57 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 72 hour Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
HT-29	IC₅₀	7.8 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 24 hour Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
K562	IC₅₀	> 5 μM Compound: DNR	Cytotoxicity against doxorubicin-resistant K562 cell line by MTS assay Cytotoxicity against doxorubicin-resistant K562 cell line by MTS assay	[PMID: 16509594]
K562	IC₅₀	0.015 μM Compound: DNR	Cytotoxicity against drug-sensitive K562 cell line by MTS assay Cytotoxicity against drug-sensitive K562 cell line by MTS assay	[PMID: 16509594]
K562	IC₅₀	156.6 μM Compound: DNR hydrochloride	Cytotoxicity against K562 leukemia cell line done for 72 hr at 37 degree C with compound in MTS assay Cytotoxicity against K562 leukemia cell line done for 72 hr at 37 degree C with compound in MTS assay	[PMID: 16078845]
LNCaP	IC₅₀	0.011 μg/mL Compound: Daunorubicin HCl	Cytotoxicity against human LNCAP cells expressing androgen receptor after 48 hrs by MTT assay Cytotoxicity against human LNCAP cells expressing androgen receptor after 48 hrs by MTT assay	[PMID: 12141872]
MCF7	IC₅₀	0.12 μg/mL Compound: Daunorubicin HCl	Cytotoxicity against human MCF7 cells expressing estrogen receptor after 48 hrs by MTT assay Cytotoxicity against human MCF7 cells expressing estrogen receptor after 48 hrs by MTT assay	[PMID: 12141872]
MCF7	IC₅₀	0.22 μM Compound: Daunorubicin	Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay	[PMID: 17190447]
MCF7	IC₅₀	1.35 x 10^-5 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 72 hour Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
MCF7	IC₅₀	7.8 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 24 hour Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
MDA-MB-231	IC₅₀	0.25 μM Compound: Daunorubicin	Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay	[PMID: 17190447]
MOLT-4	IC₅₀	1 nM Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 24 hour Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
MOLT-4	IC₅₀	8.55 x 10^-13 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 72 hour Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
NHDF	IC₅₀	1.9 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 24 hour Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
NHDF	IC₅₀	4.04 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 72 hour Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
OVCAR-3	IC₅₀	2.87 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 72 hour Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
OVCAR-3	IC₅₀	3.9 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 24 hour Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
P388	IC₅₀	< 9.8 x 10^-8 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 72 hour Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
P388	IC₅₀	3.9 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 24 hour Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
PC-3	IC₅₀	0.23 μg/mL Compound: Daunorubicin HCl	Cytotoxicity against human PC3 cells after 48 hrs by MTT assay Cytotoxicity against human PC3 cells after 48 hrs by MTT assay	[PMID: 12141872]
PC-3	IC₅₀	0.44 μM Compound: Daunorubicin	Cytotoxicity against human PC-3 cells after 48 hrs by MTT assay Cytotoxicity against human PC-3 cells after 48 hrs by MTT assay	[PMID: 17190447]
SK-MEL-28	IC₅₀	1.41 μM Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 72 hour Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 72 hour	10.1016/S0960-894X(00)80285-1
SK-MEL-28	IC₅₀	1.6 μM Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 24 hour Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1
SW-620	IC₅₀	8.6 μM Compound: DNR hydrochloride	Cytotoxicity against SW620 colon cancer cell line done for 72 h at 37 degree C with compound in MTS assay Cytotoxicity against SW620 colon cancer cell line done for 72 h at 37 degree C with compound in MTS assay	[PMID: 16078845]
UCLA P-3	IC₅₀	7.3 x 10^-7 M Compound: 1 (Daunomycin hydrochloride)	Cytotoxicity of compound was tested against UCLA P-3 cell line (lung carcinoma) after incubation for 24 hour Cytotoxicity of compound was tested against UCLA P-3 cell line (lung carcinoma) after incubation for 24 hour	10.1016/S0960-894X(00)80285-1

In Vitro

Daunorubicin hydrochloride (0-256 μg/mL, 30 min) inhibits DNA and RNA synthesis in sensitive and resistant Ehrlich ascites tumor cells^[2].
Daunorubicin hydrochloride (7 nM-1.9 μM, 72 h) shows chemosensitivity in Molt-4 cells and L3.6 cells^[3]^[4].
Daunorubicin hydrochloride (0.4 μM, 48 h) induces apoptotic and necrosis in L3.6 cells^[4].
Daunorubicin hydrochloride (0.4 μM, 120 min) induces ROS generation in L3.6 cells^[4].
Daunorubicin hydrochloride (2 μM, 24 h) induces autophagy in K562 cells (myeloid cell line)^[6].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[3]^[4]

Cell Line:	Molt-4 cells (a human T-lymphoblastic leukemia cell line), L3.6 cells (metastatic human pancreatic cell line)
Concentration:	7 nM-1.9 μM
Incubation Time:	72 h
Result:	Inhibited cell viability with IC₅₀ values of 40 nM (Molt-4) and 400 nM (L3.6).

Apoptosis Analysis^[4]

Cell Line:	L3.6 cells
Concentration:	0.4 μM
Incubation Time:	72 h
Result:	Induced necrosis without apoptosis at 24 h, induced both an apoptotic and extensive necrotic response at 48 h.

Western Blot Analysis^[6]:

Cell Line:	K562 cells
Concentration:	2 μM
Incubation Time:	24 h
Result:	Enabled the switch of LC3-I into LC3-II, accompanied with a significant increased expression level of LC3.

In Vivo

Daunorubicin hydrochloride (intravenous injection, 3 mg/kg, three times at 48 h intervals.) produces cardiotoxicity and nephrotoxicity in rats^[5].
Daunorubicin hydrochloride (intraperitoneal injection, 10 mg/kg) induces sister chromatid exchanges in mice^[7].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male Sprague-Dawley rats^[5]
Dosage:	3 mg/kg
Administration:	Intravenous injection, three times at 48 h intervals.
Result:	Caused a significant increase in MDA (malondialdehyde) level in renal tissue, accompanied by a significant reduction in total GPx activity. Increased urinary protein excretion, serum creatinine, and BUN level.

Clinical Trial

Molecular Weight

563.98

Formula

C₂₇H₃₀ClNO₁₀

CAS No.

23541-50-6

Appearance

Solid

Color

Pink to red

SMILES

O=C(C(C(OC)=CC=C1)=C1C2=O)C3=C2C(O)=C(C[C@@](O)(C(C)=O)C[C@@H]4O[C@@]5([H])C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O.[H]Cl

Structure Classification

Initial Source

Microorganisms

Streptomyces coeruleorubidus

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Solvent & Solubility

In Vitro:

DMSO : 50 mg/mL (88.66 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H₂O : ≥ 34 mg/mL (60.29 mM)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.7731 mL	8.8656 mL	17.7311 mL
5 mM	0.3546 mL	1.7731 mL	3.5462 mL
10 mM	0.1773 mL	0.8866 mL	1.7731 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (3.69 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (3.69 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: PBS
Solubility: 33.33 mg/mL (59.10 mM); Clear solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).

Purity & Documentation

Purity: 99.67%

Select Batch:

Data Sheet (287 KB) SDS (644 KB)

COA (258 KB) HNMR (135 KB) LCMS (93 KB)

Handling Instructions (2659 KB)

References

[1]. Lehmann M, et al. Activity of topoisomerase inhibitors daunorubicin, idarubicin, and aclarubicin in the Drosophila Somatic Mutation and Recombination Test. Environ Mol Mutagen. 2004;43(4):250-7. [Content Brief]

[2]. Dano K, et al. Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro. Cancer Res. 1972 Jun;32(6):1307-14. [Content Brief]

[3]. Svensson SP, et al. Melanin inhibits cytotoxic effects of Doxorubicin and Daunorubicin in MOLT 4 cells. Pigment Cell Res. 2003 Aug;16(4):351-4 [Content Brief]

[4]. Gervasoni JE Jr, et al. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and Daunorubicin by induction of both necrosis and apoptosis. Anticancer Res. 2004 Sep-Oct;24(5A):2617-26 [Content Brief]

[5]. Arozal W, et al. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions. Toxicology. 2011 Jan 11;279(1-3):91-9. [Content Brief]

[6]. Emeline Bollaert, et al. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin. Int J Mol Sci. 2021 May 13;22(10):5153. [Content Brief]

[7]. Cheng Wu, et al. Doxorubicin suppresses chondrocyte differentiation by stimulating ROS production. Eur J Pharm Sci. 2021 Dec 1;167:106013. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

H₂O / DMSO	1 mM	1.7731 mL	8.8656 mL	17.7311 mL	44.3278 mL
	5 mM	0.3546 mL	1.7731 mL	3.5462 mL	8.8656 mL
	10 mM	0.1773 mL	0.8866 mL	1.7731 mL	4.4328 mL
	15 mM	0.1182 mL	0.5910 mL	1.1821 mL	2.9552 mL
	20 mM	0.0887 mL	0.4433 mL	0.8866 mL	2.2164 mL
	25 mM	0.0709 mL	0.3546 mL	0.7092 mL	1.7731 mL
	30 mM	0.0591 mL	0.2955 mL	0.5910 mL	1.4776 mL
	40 mM	0.0443 mL	0.2216 mL	0.4433 mL	1.1082 mL
	50 mM	0.0355 mL	0.1773 mL	0.3546 mL	0.8866 mL
	60 mM	0.0296 mL	0.1478 mL	0.2955 mL	0.7388 mL
DMSO	80 mM	0.0222 mL	0.1108 mL	0.2216 mL	0.5541 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Daunorubicin hydrochloride Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社
Product Name			Salutation
Applicant Name *			Email Address *
Phone Number *			Organization Name *
Department *			Requested quantity *
Country or Region *
Remarks

Product Name			Lot #
Applicant Name *			Email Address *
Phone Number			Department *
Organization Name *			Country or Region *
Remarks

Daunorubicin hydrochloride (Synonyms: Daunomycin hydrochloride; RP 13057 hydrochloride; Rubidomycin hydrochloride)

Customer Review

Other Forms of Daunorubicin hydrochloride:

25 Publications Citing Use of MCE Daunorubicin hydrochloride

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All Topoisomerase Isoform Specific Products:

View All ADC Cytotoxin Isoform Specific Products:

View All Antibiotic Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Daunorubicin hydrochloride Related Classifications

Keywords:

Your Recently Viewed Products:

Daunorubicin hydrochloride (Synonyms: Daunomycin hydrochloride; RP 13057 hydrochloride; Rubidomycin hydrochloride)

Customer Review

Other Forms of Daunorubicin hydrochloride:

Daunorubicin hydrochloride Related Antibodies

25 Publications Citing Use of MCE Daunorubicin hydrochloride

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All Topoisomerase Isoform Specific Products:

View All ADC Cytotoxin Isoform Specific Products:

View All Antibiotic Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

Daunorubicin hydrochloride Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Daunorubicin hydrochloride Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report